Not a bad half yearly from a quick glance. NTA is still ticking up nicely - and still a tad above current share price.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025